Lindynette 20

Ethinylestradiol, the active ingredient in Lindynette 20, is a combined oral contraceptive presented as a 20 µg/0.075 mg oral tablet for oral use. Together with gestodene, it works to prevent pregnancy in women of reproductive age by inhibiting ovulation and altering cervical mucus.\n\nGNH India supplies Lindynette 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU regulatory standards and is manufactured under strict quality controls.

Lindynette 20, a combined oral contraceptive, is indicated for hormonal contraception in women.\n\nContraception (prevention of pregnancy): reliable reversible prevention of pregnancy when taken as directed.\nDysmenorrhea: reduction of menstrual pain through hormonal stabilization.\nMenstrual cycle regulation: helps achieve more predictable bleeding patterns.

Lindynette 20 may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Nausea: mild to moderate stomach upset.\n- Breast tenderness: temporary swelling or soreness.\n- Headache: occasional mild to moderate pain.\n- Spotting or breakthrough bleeding: irregular light bleeding between periods.\n- Weight gain: modest increase in body weight.\n- Mood changes: irritability or mood swings.\n\nSerious or Rare Side Effects:\n- Venous thromboembolism: deep‑vein clot formation.\n- Arterial thrombosis: stroke or myocardial infarction risk.\n- Severe hypertension: sudden high blood pressure.\n- Liver disorders: cholestatic jaundice or hepatic adenoma.\n- Anaphylaxis: life‑threatening allergic reaction.

Before prescribing Lindynette 20, clinicians should evaluate individual risk factors and counsel patients on safe use.\n\nMedical review: assess thromboembolic risk, cardiovascular disease, and liver function.\nSmoking: avoid use in women over 35 who smoke.\nDrug interactions: review concomitant medications that may affect efficacy.\nPregnancy: discontinue immediately if pregnancy is confirmed.\nBreastfeeding: discuss potential risks with a healthcare provider.\nStore at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Lindynette 20 can interact with several medicines, altering its effectiveness or safety profile.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.\n- Anticoagulants (e.g., warfarin): hormonal changes can affect clotting parameters.\n\nModerate Interactions (Monitor Closely):\n- Antifungals (e.g., ketoconazole, itraconazole): may increase hormone levels, raising side‑effect risk.\n- Selective serotonin reuptake inhibitors (SSRIs): can alter bleeding patterns.\n- Herbal supplements (e.g., St. John’s wort): may diminish contraceptive effectiveness.